Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0105EUR
−6.94 MEUR
7.91 MEUR
1.19 B
About SYNTARA LIMITED
Sector
CEO
Gary Jonathan Phillips
Headquarters
Sydney
Website
Founded
1998
ISIN
AU0000312480
FIGI
BBG000K9SYC9
Syntara Ltd. is a pharmaceutical research company, which engages in the development and commercialization of healthcare products for fibrotic and inflammatory diseases. Its respiratory products include bronchitol and aridol. The company was founded by Brett Charlton and William B. Cowden on May 29, 1998 and is headquartered in Sydney, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SYNTARA LTD. stocks are traded under the ticker UUDA.
We've gathered analysts' opinions on SYNTARA LTD. future price: according to them, UUDA price has a max estimate of 0.12 EUR and a min estimate of 0.12 EUR. Watch UUDA chart and read a more detailed SYNTARA LTD. stock forecast: see what analysts think of SYNTARA LTD. and suggest that you do with its stocks.
UUDA reached its all-time high on Feb 16, 2024 with the price of 0.0160 EUR, and its all-time low was 0.0080 EUR and was reached on Feb 21, 2024. View more price dynamics on UUDA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track SYNTARA LTD. financials in yearly and quarterly reports right on TradingView.
SYNTARA LTD. is going to release the next earnings report on Aug 14, 2024. Keep track of upcoming events with our Earnings Calendar.
UUDA net income for the last quarter is −3.67 M EUR, while the quarter before that showed −3.96 M EUR of net income which accounts for 7.32% change. Track more SYNTARA LTD. financial stats to get the full picture.
No, UUDA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNTARA LTD. EBITDA is −7.62 M EUR, and current EBITDA margin is −121.38%. See more stats in SYNTARA LTD. financial statements.
Like other stocks, UUDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNTARA LTD. stock right from TradingView charts — choose your broker and connect to your account.